331 related articles for article (PubMed ID: 25505789)
1. The neural crest lineage as a driver of disease heterogeneity in Tuberous Sclerosis Complex and Lymphangioleiomyomatosis.
Delaney SP; Julian LM; Stanford WL
Front Cell Dev Biol; 2014; 2():69. PubMed ID: 25505789
[TBL] [Abstract][Full Text] [Related]
2. [
Verwer EE; Kavanagh TR; Mischler WJ; Feng Y; Takahashi K; Wang S; Shoup TM; Neelamegam R; Yang J; Guehl NJ; Ran C; Massefski W; Cui Y; El-Chemaly S; Sadow PM; Oldham WM; Kijewski MF; El Fakhri G; Normandin MD; Priolo C
Clin Cancer Res; 2018 Dec; 24(23):5925-5938. PubMed ID: 30054282
[TBL] [Abstract][Full Text] [Related]
3. Mutation analysis of the TSC1 and TSC2 genes in Japanese patients with pulmonary lymphangioleiomyomatosis.
Sato T; Seyama K; Fujii H; Maruyama H; Setoguchi Y; Iwakami S; Fukuchi Y; Hino O
J Hum Genet; 2002; 47(1):20-8. PubMed ID: 11829138
[TBL] [Abstract][Full Text] [Related]
4. Lymphangioleiomyomatosis Association with Underlying Genotype in Patients with Tuberous Sclerosis Complex.
Tian X; Glass JE; Kwiatkowski DJ; Towbin AJ; Li Y; Sund KL; Krueger DA; Franz DN; McCormack FX; Gupta N
Ann Am Thorac Soc; 2021 May; 18(5):815-819. PubMed ID: 33171065
[No Abstract] [Full Text] [Related]
5. Pathogenesis of multifocal micronodular pneumocyte hyperplasia and lymphangioleiomyomatosis in tuberous sclerosis and association with tuberous sclerosis genes TSC1 and TSC2.
Maruyama H; Ohbayashi C; Hino O; Tsutsumi M; Konishi Y
Pathol Int; 2001 Aug; 51(8):585-94. PubMed ID: 11564212
[TBL] [Abstract][Full Text] [Related]
6. Immunotherapy for Lymphangioleiomyomatosis and Tuberous Sclerosis: Progress and Future Directions.
Liu HJ; Krymskaya VP; Henske EP
Chest; 2019 Dec; 156(6):1062-1067. PubMed ID: 31437431
[TBL] [Abstract][Full Text] [Related]
7. A patient with TSC1 germline mutation whose clinical phenotype was limited to lymphangioleiomyomatosis.
Sato T; Seyama K; Kumasaka T; Fujii H; Setoguchi Y; Shirai T; Tomino Y; Hino O; Fukuchi Y
J Intern Med; 2004 Aug; 256(2):166-73. PubMed ID: 15257730
[TBL] [Abstract][Full Text] [Related]
8. TSC2 epigenetic defect in primary LAM cells. Evidence of an anchorage-independent survival.
Lesma E; Ancona S; Sirchia SM; Orpianesi E; Grande V; Colapietro P; Chiaramonte E; Di Giulio AM; Gorio A
J Cell Mol Med; 2014 May; 18(5):766-79. PubMed ID: 24606538
[TBL] [Abstract][Full Text] [Related]
9. Evidence that lymphangiomyomatosis is caused by TSC2 mutations: chromosome 16p13 loss of heterozygosity in angiomyolipomas and lymph nodes from women with lymphangiomyomatosis.
Smolarek TA; Wessner LL; McCormack FX; Mylet JC; Menon AG; Henske EP
Am J Hum Genet; 1998 Apr; 62(4):810-5. PubMed ID: 9529362
[TBL] [Abstract][Full Text] [Related]
10. The spectrum of mutations in TSC1 and TSC2 in women with tuberous sclerosis and lymphangiomyomatosis.
Strizheva GD; Carsillo T; Kruger WD; Sullivan EJ; Ryu JH; Henske EP
Am J Respir Crit Care Med; 2001 Jan; 163(1):253-8. PubMed ID: 11208653
[TBL] [Abstract][Full Text] [Related]
11. Rapamycin-insensitive up-regulation of adipocyte phospholipase A2 in tuberous sclerosis and lymphangioleiomyomatosis.
Li C; Zhang E; Sun Y; Lee PS; Zhan Y; Guo Y; Osorio JC; Rosas IO; Xu KF; Kwiatkowski DJ; Yu JJ
PLoS One; 2014; 9(10):e104809. PubMed ID: 25347447
[TBL] [Abstract][Full Text] [Related]
12. Human Pluripotent Stem Cell-Derived
Julian LM; Delaney SP; Wang Y; Goldberg AA; Doré C; Yockell-Lelièvre J; Tam RY; Giannikou K; McMurray F; Shoichet MS; Harper ME; Henske EP; Kwiatkowski DJ; Darling TN; Moss J; Kristof AS; Stanford WL
Cancer Res; 2017 Oct; 77(20):5491-5502. PubMed ID: 28830860
[TBL] [Abstract][Full Text] [Related]
13. Tuberous sclerosis complex for the pulmonologist.
Rebaine Y; Nasser M; Girerd B; Leroux C; Cottin V
Eur Respir Rev; 2021 Sep; 30(161):. PubMed ID: 34348978
[TBL] [Abstract][Full Text] [Related]
14. Detection of low-prevalence somatic TSC2 mutations in sporadic pulmonary lymphangioleiomyomatosis tissues by deep sequencing.
Fujita A; Ando K; Kobayashi E; Mitani K; Okudera K; Nakashima M; Miyatake S; Tsurusaki Y; Saitsu H; Seyama K; Miyake N; Matsumoto N
Hum Genet; 2016 Jan; 135(1):61-8. PubMed ID: 26563443
[TBL] [Abstract][Full Text] [Related]
15. Mutational analysis of the tuberous sclerosis gene TSC2 in patients with pulmonary lymphangioleiomyomatosis.
Astrinidis A; Khare L; Carsillo T; Smolarek T; Au KS; Northrup H; Henske EP
J Med Genet; 2000 Jan; 37(1):55-7. PubMed ID: 10633137
[TBL] [Abstract][Full Text] [Related]
16. Animal models of lymphangioleiomyomatosis (LAM) and tuberous sclerosis complex (TSC).
Kwiatkowski DJ
Lymphat Res Biol; 2010 Mar; 8(1):51-7. PubMed ID: 20235887
[TBL] [Abstract][Full Text] [Related]
17. Tuberous Sclerosis Complex: State-of-the-Art Review with a Focus on Pulmonary Involvement.
von Ranke FM; Zanetti G; e Silva JL; Araujo Neto CA; Godoy MC; Souza CA; Mançano AD; Souza AS; Escuissato DL; Hochhegger B; Marchiori E
Lung; 2015 Oct; 193(5):619-27. PubMed ID: 26104489
[TBL] [Abstract][Full Text] [Related]
18. A Case of Tuberous Sclerosis Complex with Lymphangioleiomyomatosis and Renal Cell Carcinoma.
Wu Y; Li H; Yu X; Lin M; Chen Y
Onco Targets Ther; 2020; 13():12421-12426. PubMed ID: 33293833
[TBL] [Abstract][Full Text] [Related]
19. Lymphangioleiomyomatosis and tuberous sclerosis complex.
Chorianopoulos D; Stratakos G
Lung; 2008; 186(4):197-207. PubMed ID: 18408969
[TBL] [Abstract][Full Text] [Related]
20. Tuberous sclerosis complex associated lymphangioleiomyomatosis caused by de novo mutation of
Van Luong D; Huy LN; Giang NX; Thu NHH; Ha NH; Binh NH
Respirol Case Rep; 2024 Apr; 12(4):e01346. PubMed ID: 38596252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
